TRIM32 and lung carcinoma: TRIM32 overexpression promotes lung cancer cell proliferation by activating the JAK2/STAT3-signaling pathway [131], as STAT3 has also been implied in muscle wasting during cancer [132], it would be interesting to test if TRIM32 also activates this inflammatory pathway in muscles.